Literature DB >> 9523589

Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system.

A A Habib1, L S Marton, B Allwardt, J R Gulcher, D D Mikol, T Högnason, N Chattopadhyay, K Stefansson.   

Abstract

The oligodendrocyte-myelin glycoprotein (OMgp) is a 110-kDa glycosylphosphatidylinositol-linked protein that was initially identified as a myelin-specific protein but whose precise function remains unknown. In this study, immunohistochemistry, western blots, in situ hybridization, and northern blots were used to determine the distribution of OMgp in the mouse brain. OMgp is present in a concentration detectable on western blots in the brains of newborn mice, and its concentration gradually increases until day 24 of life. OMgp mRNA is also present in amounts detectable on northern blots in the brains of newborn mice, and its concentration gradually increases until day 21 of life, after which the concentration diminishes a little. Most of the OMgp in the mouse brain appears to be expressed in diverse groups of neurons, but it is particularly prominent in large projection neurons such as the pyramidal cells of the hippocampus, the Purkinje cells of the cerebellum, motoneurons in the brainstem, and anterior horn cells of the spinal cord. However, OMgp is not confined to these cells and is expressed in cells in the white matter as well. The OMgp gene is placed within an intron of the neurofibromatosis type I gene and on the opposite strand. This organization raises the possibility that there may be a relationship between the functions of the products of the two genes. In support of this possibility, we show that within the mouse CNS OMgp and neurofibromin are expressed in the same cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9523589     DOI: 10.1046/j.1471-4159.1998.70041704.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

1.  Oligodendrocyte myelin glycoprotein does not influence node of ranvier structure or assembly.

Authors:  Kae-Jiun Chang; Keiichiro Susuki; Maria T Dours-Zimmermann; Dieter R Zimmermann; Matthew N Rasband
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

Review 2.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 3.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 4.  The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury.

Authors:  Sari S Hannila; Marie T Filbin
Journal:  Exp Neurol       Date:  2007-08-27       Impact factor: 5.330

Review 5.  Central nervous system regeneration inhibitors and their intracellular substrates.

Authors:  Michelle Nash; Horia Pribiag; Alyson E Fournier; Christian Jacobson
Journal:  Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.590

6.  The expression patterns of Nogo-A, myelin associated glycoprotein and oligodendrocyte myelin glycoprotein in the retina after ocular hypertension: the expression of myelin proteins in the retina in glaucoma.

Authors:  Xin-Xue Liao; Dong Chen; Jianbo Shi; Yue-Qi Sun; Shu-Juan Sun; Kwok-Fai So; Qing-Ling Fu
Journal:  Neurochem Res       Date:  2011-06-04       Impact factor: 3.996

Review 7.  Mechanisms of Axonal Damage and Repair after Central Nervous System Injury.

Authors:  Naohiro Egawa; Josephine Lok; Kazuo Washida; Ken Arai
Journal:  Transl Stroke Res       Date:  2016-08-27       Impact factor: 6.829

Review 8.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

9.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

10.  TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system.

Authors:  Stefan Bittner; Sven G Meuth; Kerstin Göbel; Nico Melzer; Alexander M Herrmann; Ole J Simon; Andreas Weishaupt; Thomas Budde; Douglas A Bayliss; Martin Bendszus; Heinz Wiendl
Journal:  Brain       Date:  2009-07-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.